Tag Archives: Europe

HTAs Impact on Biosimilars in Europe

Cuts in healthcare costs due to post-recession austerity programs mean favorable Health Technology Assessments (HTAs) are becoming crucial to the successful market launch of pharmaceuticals in Europe. HTAs backing reimbursement can be vital for new innovative medicines and also for biosimilars. EUnetHTA has been stepping up its efforts to achieve more consistency in the methodology […]
Posted in Europe, Regulatory | Also tagged , , , , | Leave a comment

How Good for UK Pharma is the European Union?

As the United Kingdom debate about whether to stay in the European Union becomes more bitter and intense, an insight into how EU membership impacts on medicines and pharmaceuticals has appeared from a British politician who was until recently the UK Government Adviser on Life Sciences, George Freeman. His view—which is less than rosy—is worth […]
Posted in Europe, Global, Guest Blog, Regulatory | Also tagged , , , , | 1 Comment

Type 2 Diabetes Opportunities in Europe "Vast", Says Report

“Vast” Diabetes Opportunities in Europe, Says Report The European type 2 diabetes market earned revenues of €9.50 billion in 2009 and is estimated to reach €15.46 billion in 2017 (CAGR 3.8 percent), according to new research by Frost & Sullivan. The International Diabetes Federation states that more than 55 million people have been diagnosed with […]
Posted in Europe, healthcare | Also tagged , , , , , , , | Leave a comment

The EMA Turns 20: What Does It Want to Be?

Reflector looks at the growing pains of the European Medicine Agency (EMA) as it faces the key policy challenges of 2014. The European Medicines Agency (EMA) is 20 years old this year — and it confronts many of the problems familiar to anyone at that age. After the vigorous growth and boundless optimism of its […]
Posted in Europe, Global, Regulatory | Also tagged , , , , | Leave a comment

Europe: Early Communications with Regulators is Essential for SMEs

With SMEs gaining wider recognition as the powerhouse of research and innovation in Europe, regulatory agencies are urging companies to engage with regulators early in the drug-development process. Europe’s regulatory agencies have been stepping up their support for small- and medium-sized enterprises (SMEs), including micro companies, in an effort to stimulate more development of innovative […]
Posted in Europe, Global, Guest Blog, Op-Ed, Regulatory | Also tagged , , , , | Leave a comment
  • Categories

  • Meta